XYMOGEN identifies allergen oversight by third-party manufacturer; issues recall of artriphen™
date:May 09, 2013
luded in the products labeling while preparing to buy artriphen in bulk and then label and package it for the first time at its new 136,000-square-foot manufacturing facility and headquarters in Orlando.

We were afraid the manufacturer had been fraudulently labeling the product after we received from them our mandatory allergen checklist, indicating both allergens as present in the formula, Blackburn said. After questioning them on this discovery, we were able to confirm this was the case and t
4/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/09 01:37